All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
XS-1122-YF2650 | Anti-SLC22A12 TCR-ABR (scFv-TCRβ, XW-810) CAR Plasmid, pCDCAR1 | Human | XW-810 | Rabbit | scFv-TCRβ | Lentiviral vector | T Cell | ||
XS-1122-YF2651 | Anti-SLC22A12 TCR-ABR (scFv-TCRβ, XW-811) CAR Plasmid, pCDCAR1 | Human | XW-811 | Mouse | scFv-TCRβ | Lentiviral vector | T Cell | ||
XS-1122-YF2652 | Anti-SLC22A12 TCR-ABR (scFv-TCRβ, XW-812) CAR Plasmid, pCDCAR1 | Mouse | XW-812 | Rat | scFv-TCRβ | Lentiviral vector | T Cell | ||
XS-1122-YF3570 | Anti-SLC22A12 TCR-ABR (scFv-CD3γ, XW-810) CAR Plasmid, pCDCAR1 | Human | XW-810 | Rabbit | scFv-CD3γ | Lentiviral vector | T Cell | ||
XS-1122-YF3571 | Anti-SLC22A12 TCR-ABR (scFv-CD3γ, XW-811) CAR Plasmid, pCDCAR1 | Human | XW-811 | Mouse | scFv-CD3γ | Lentiviral vector | T Cell | ||
XS-1122-YF3572 | Anti-SLC22A12 TCR-ABR (scFv-CD3γ, XW-812) CAR Plasmid, pCDCAR1 | Mouse | XW-812 | Rat | scFv-CD3γ | Lentiviral vector | T Cell | ||
XS-1122-YF4490 | Anti-SLC22A12 TCR-ABR (scFv-CD3δ, XW-810) CAR Plasmid, pCDCAR1 | Human | XW-810 | Rabbit | scFv-CD3δ | Lentiviral vector | T Cell | ||
XS-1122-YF4491 | Anti-SLC22A12 TCR-ABR (scFv-CD3δ, XW-811) CAR Plasmid, pCDCAR1 | Human | XW-811 | Mouse | scFv-CD3δ | Lentiviral vector | T Cell | ||
XS-1122-YF4492 | Anti-SLC22A12 TCR-ABR (scFv-CD3δ, XW-812) CAR Plasmid, pCDCAR1 | Mouse | XW-812 | Rat | scFv-CD3δ | Lentiviral vector | T Cell | ||
XS-1122-YF5410 | Anti-SLC22A12 TCR-ABR (scFv-CD3ε, XW-810) CAR Plasmid, pCDCAR1 | Human | XW-810 | Rabbit | scFv-CD3ε | Lentiviral vector | T Cell | ||
XS-1122-YF5411 | Anti-SLC22A12 TCR-ABR (scFv-CD3ε, XW-811) CAR Plasmid, pCDCAR1 | Human | XW-811 | Mouse | scFv-CD3ε | Lentiviral vector | T Cell | ||
XS-1122-YF8170 | Anti-SLC22A12 (XW-810) h(CD28-41BB-CD3ζ) CAR, pAAV | Human | XW-810 | Rabbit | scFv-CD28-41BB-CD3ζ | Adeno-associated viral (AAV) vector | T Cell | ||
XS-1122-YF8171 | Anti-SLC22A12 (XW-811) h(CD28-41BB-CD3ζ) CAR, pAAV | Human | XW-811 | Mouse | scFv-CD28-41BB-CD3ζ | Adeno-associated viral (AAV) vector | T Cell | ||
XS-1122-YF8172 | Anti-SLC22A12 (XW-812) h(CD28-41BB-CD3ζ) CAR, pAAV | Mouse | XW-812 | Rat | scFv-CD28-41BB-CD3ζ | Adeno-associated viral (AAV) vector | T Cell | ||
XS-0123-ZP317 | Anti-SLC22A12 (DS3292AB) h(scFv-CD3ε) TRuC, pCDTRC1 | Human | DS3292AB | Rabbit | scFv-CD3ε | Lentiviral vector | T cell | ||
XS-0123-ZP318 | Anti-SLC22A12 (8G2) h(scFv-CD3ε) TRuC, pCDTRC1 | Human | 8G2 | Mouse | scFv-CD3ε | Lentiviral vector | T cell | ||
XS-0123-ZP553 | Anti-SLC22A12 (CB-P42) h(scFv-CD3ε) TRuC, pCDTRC1 | Mouse | CB-P42 | Rat | scFv-CD3ε | Lentiviral vector | T cell | ||
XS-0323-ZP317 | Anti-SLC22A12 (DS3292AB scFv-CD28TM-CD79β) CBCR(CAR-B), pCDCAR1 | Human | DS3292AB | Rabbit | scFv-CD28TM-CD79β | Lentiviral vector | T cell | CAR-B Vector | |
XS-0323-ZP318 | Anti-SLC22A12 (8G2 scFv-CD28TM-CD79β) CBCR(CAR-B), pCDCAR1 | Human | 8G2 | Mouse | scFv-CD28TM-CD79β | Lentiviral vector | T cell | CAR-B Vector | |
XS-0323-ZP553 | Anti-SLC22A12 (CB-P42 scFv-CD28TM-CD79β) CBCR(CAR-B), pCDCAR1 | Mouse | CB-P42 | Rat | scFv-CD28TM-CD79β | Lentiviral vector | T cell | CAR-B Vector |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION